Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials

Biologic disease modifying antirheumatic drugs (bDMARDs) and Janus Kinase (JAK) inhibitors are prescribed in adult and paediatric rheumatology. Due to age-dependent changes, disease course, and pharmacokinetic...

Source: Pediatric Rheumatology - March 25, 2021 Category: Rheumatology Authors: Tatjana Welzel, Carolyn Winskill, Nancy Zhang, Andreas Woerner and Marc Pfister Tags: Review Source Type: research